2m 2m 2m 2m 2m 2m 2m
PRECIGEN (PGEN)
NASDAQ
$6.29+$0.02 (+0.24%)
Price as of Aug 03, 2026 7:36 AM EDT- $2.2BMarket Cap
- 275.45%1-Year Change
- BiotechnologyIndustry
PRECIGEN (PGEN)
$6.29+$0.02 (+0.24%)
PGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.27 | ||
Change | +$0.33 (+5.56%) | ||
Open | $5.94 | ||
High | $6.28 | ||
Low | $5.92 | ||
Previous Close | $5.94 | ||
Volume | 5,624,066 | ||
30-Day Average Volume | 4,042,406 | ||
1-Week Change | 16.11% | ||
1-Month Change | 10.00% | ||
1-Year Change | 275.45% | ||
3-Year Change | 351.08% | ||
5-Year Change | 14.21% | ||
Fundamentals | |||
Shares Outstanding | 356.5M | ||
Total Assets | $138.6M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $21.8M | ||
Net Income | -$7.9M | ||
Free Cash Flow | -$44.1M | ||
EBIT | -$5.0M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $80.6M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -592 | ||
Enterprise Value/Revenue | 106 | ||
P/B | 110 | ||
P/E | -314 | ||
PEG | -4 | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue